colistimethate sodium has been researched along with Bacterial Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Almirante, B; Basas, J; Gainza, E; Gainza, G; Gavaldà, J; Gomis, X; Hernandez, RM; Igartua, M; Palau, M; Pastor, M; Vairo, C | 1 |
| Abril-López de Medrano, V; Gimeno-Cardona, C; Ortega-García, MP | 1 |
| Balducci, AG; Buttini, F; Colombo, G; Di Cuia, M; Elviri, L; Rossi, A; Rossi, I; Sonvico, F | 1 |
| Nation, RL; Zavascki, AP | 1 |
| Ake, J; Hartzell, JD; Howard, R; Neff, R; Olson, S; Paolino, K; Vishnepolsky, M; Weintrob, A; Wortmann, G | 1 |
| Horton, J; Pankey, GA | 1 |
| Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 1 |
2 review(s) available for colistimethate sodium and Bacterial Infections
| Article | Year |
|---|---|
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Bacterial Infections; Biological Transport; Clinical Trials as Topic; Colistin; Humans; Kidney; Mice; Polymyxin B; Prodrugs; Rats; Survival Analysis | 2017 |
Polymyxin B, colistin, and sodium colistimethate.
Topics: Bacteria; Bacterial Infections; Colistin; Humans; Kinetics; Polymyxin B; Polymyxins | 1982 |
1 trial(s) available for colistimethate sodium and Bacterial Infections
| Article | Year |
|---|---|
Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Colistin; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Leukemia; Middle Aged; Nicotinic Acids; Nystatin; Pipemidic Acid; Pneumonia; Random Allocation | 1989 |
4 other study(ies) available for colistimethate sodium and Bacterial Infections
| Article | Year |
|---|---|
In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC).
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Colistin; Drug Carriers; Drug Resistance, Bacterial; Humans; Lipids; Nanostructures; Pseudomonas aeruginosa | 2020 |
[Changes in the dosing of colistimethate sodium in critically ill patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Colistin; Critical Care; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans | 2016 |
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Colistin; Cystic Fibrosis; Humans; Lung Diseases; Nebulizers and Vaporizers; Solutions | 2016 |
Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Colistin; Female; Humans; Incidence; Injections, Intravenous; Male; Renal Insufficiency; United States; Withholding Treatment; Young Adult | 2009 |